DNARx is developing multiple therapeutics for major unmet medical needs. The company has demonstrated vaccine capabilities as well as protein expression from HEDGES, enabling the company to pursue novel, proprietary therapeutics in flu, hemophilia, hematology, oncology, as well as other indications.

RESEARCH PIPELINE